294 related articles for article (PubMed ID: 11976594)
1. [Primary progressive forms of multiple sclerosis: application of the new diagnostic criteria in French].
De Seze J; Mackowiak A; Stojkovic T; Ferriby D; Hautecoeur P; Vermersch P
Rev Neurol (Paris); 2002 Mar; 158(3):341-5. PubMed ID: 11976594
[TBL] [Abstract][Full Text] [Related]
2. [Late onset multiple sclerosis].
Delalande S; De Seze J; Ferriby D; Stojkovic T; Vermersch P
Rev Neurol (Paris); 2002 Nov; 158(11):1082-7. PubMed ID: 12451340
[TBL] [Abstract][Full Text] [Related]
3. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
Lebrun C; Bensa C; Debouverie M; Wiertlevski S; Brassat D; de Seze J; Rumbach L; Pelletier J; Labauge P; Brochet B; Tourbah A; Clavelou P;
Arch Neurol; 2009 Jul; 66(7):841-6. PubMed ID: 19597085
[TBL] [Abstract][Full Text] [Related]
4. Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.
Montalban X; Sastre-Garriga J; Filippi M; Khaleeli Z; Téllez N; Vellinga MM; Tur C; Brochet B; Barkhof F; Rovaris M; Miller DH; Polman CH; Rovira A; Thompson AJ
Mult Scler; 2009 Dec; 15(12):1459-65. PubMed ID: 19995843
[TBL] [Abstract][Full Text] [Related]
5. The natural history of primary progressive multiple sclerosis.
Koch M; Kingwell E; Rieckmann P; Tremlett H
Neurology; 2009 Dec; 73(23):1996-2002. PubMed ID: 19996074
[TBL] [Abstract][Full Text] [Related]
6. [Multiple sclerosis in Peru. A clinical-epidemiological description of a series of patients].
Vizcarra-Escobar D; Cava-Prado L; Tipismana-Barbarán M
Rev Neurol; 2005 Nov 16-30; 41(10):591-5. PubMed ID: 16288421
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of multiple sclerosis in Lebanon.
Yamout B; Barada W; Tohme RA; Mehio-Sibai A; Khalifeh R; El-Hajj T
J Neurol Sci; 2008 Jul; 270(1-2):88-93. PubMed ID: 18367208
[TBL] [Abstract][Full Text] [Related]
8. Is late-onset multiple sclerosis associated with a worse outcome?
Tremlett H; Devonshire V
Neurology; 2006 Sep; 67(6):954-9. PubMed ID: 17000960
[TBL] [Abstract][Full Text] [Related]
9. [Clinical characterization of patients with multiple sclerosis defined in Cuba].
Cabrera-Gómez JA; Santana E; Vals O; Casanova M; Alfaro I; González-Quevedo A; Fernández R; Gómez L; Báez M; Rodríguez A; Quevedo L; Cabrera-Núñez JA
Rev Neurol; 1998 May; 26(153):723-8. PubMed ID: 9634654
[TBL] [Abstract][Full Text] [Related]
10. [Visual, early auditory and somatosensory evoked potentials in multiple sclerosis (917 cases)].
Fischer C; Mauguière F; Ibañez V; Courjon J
Rev Neurol (Paris); 1986; 142(5):517-23. PubMed ID: 3787054
[TBL] [Abstract][Full Text] [Related]
11. The natural history of primary progressive MS in British Columbia, Canada.
Tremlett H; Paty D; Devonshire V
Neurology; 2005 Dec; 65(12):1919-23. PubMed ID: 16380613
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of multiple sclerosis: comparison of the Poser criteria and the new McDonald criteria.
Fangerau T; Schimrigk S; Haupts M; Kaeder M; Ahle G; Brune N; Klinkenberg K; Kotterba S; Möhring M; Sindern E;
Acta Neurol Scand; 2004 Jun; 109(6):385-9. PubMed ID: 15147460
[TBL] [Abstract][Full Text] [Related]
13. [The diagnostic value of nuclear magnetic resonance tomography, multimodal evoked potentials and cerebrospinal fluid examination in multiple sclerosis].
Staffen W; Trinka E; Ladurner G
Nervenarzt; 1993 Apr; 64(4):226-32. PubMed ID: 8506010
[TBL] [Abstract][Full Text] [Related]
14. Clinical, MRI, CSF and electrophysiological findings in different stages of multiple sclerosis.
Rot U; Mesec A
Clin Neurol Neurosurg; 2006 Mar; 108(3):271-4. PubMed ID: 16378679
[TBL] [Abstract][Full Text] [Related]
15. A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy.
Skoog B; Runmarker B; Winblad S; Ekholm S; Andersen O
Brain; 2012 Mar; 135(Pt 3):900-11. PubMed ID: 22366800
[TBL] [Abstract][Full Text] [Related]
16. Primary progressive multiple sclerosis: a comparative study of the diagnostic criteria.
de Seze J; Debouverie M; Waucquier N; Steinmetz G; Pittion S; Zephir H; Fleury M; Blanc F; Vermersch P
Mult Scler; 2007 Jun; 13(5):622-5. PubMed ID: 17548441
[TBL] [Abstract][Full Text] [Related]
17. A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity?
Karussis D; Leker RR; Ashkenazi A; Abramsky O
Ann Neurol; 1998 Oct; 44(4):629-34. PubMed ID: 9778261
[TBL] [Abstract][Full Text] [Related]
18. [Prognostics factors of renal failure in multiple sclerosis].
Viart L; Elalouf V; Petit J; Al Khedr A; Kristkowiak P; Saint F
Prog Urol; 2012 Dec; 22(16):1026-32. PubMed ID: 23178100
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of cerebrospinal fluid in multiple sclerosis.
Siritho S; Freedman MS
J Neurol Sci; 2009 Apr; 279(1-2):21-5. PubMed ID: 19181345
[TBL] [Abstract][Full Text] [Related]
20. [Optic nerve neuritis after 50 years of age: symptom of a previously undiagnosed multiple sclerosis].
Budde WM; Schober S; Küchle M
Klin Monbl Augenheilkd; 1997 Jul; 211(1):28-31. PubMed ID: 9340402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
